Taisho Director
Taisho Pharmaceutical Co., Ltd.
19
0
17
N/A
0
11
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
+11 more interventions
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (19)
Showing 10 of 19 trials
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Tage Ramakrishna, MD
Progenics Pharmaceuticals, Inc.
Shared therapeutic areas:
Paolo Bonato, PhD
Spaulding Rehabilitation Hospital
Shared therapeutic areas:
Herbert B Slade, MD
Healthpoint
Shared therapeutic areas:
Pablo Tebas, MD
University of Pennsylvania
Shared therapeutic areas:
Hagop Youssoufian, MD
Verastem, Inc.
Shared therapeutic areas:
Leonardo G Cohen, M.D.
National Institute of Neurological Disorders and Stroke (NINDS)
Shared therapeutic areas:
James C Eisenach, MD
Wake Forest University Health Sciences
Shared therapeutic areas:
Suman Sheraz, PhD*
Riphah International University
Shared therapeutic areas:
Neal S Young, M.D.
National Heart, Lung, and Blood Institute (NHLBI)
Shared therapeutic areas:
Senior Manager
Takeda
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (19)
Showing 19 of 19 trials
A Clinical Study of TS-172 in Hyperphosphatemia Patients on Peritoneal Dialysis
A Clinical Study of TS-172 in Hyperphosphatemia Patients on Hemodialysis
An Open-label Pharmacokinetic Study of TS-172 in Patients on Hemodialysis
A Phase 2 Study of TS-172 in Hyperphosphatemia Patients on Hemodialysis With Phosphate Binders
A Phase 3 Study of TS-172 in Hyperphosphatemia Patients on Hemodialysis
A Mass Balance Study of TS-172 in Healthy Adult Subjects
A Study to Investigate the Next-day Residual Effects of TS-142 in Healthy Elderly Subjects
A Phase 2 Dose-finding Study of TS-172 in Hyperphosphatemia Patients on Hemodialysis
A Pharmacokinetic Study of TS-142 in Patients with Hepatic Impairment
Long-Term Study of TS-142 in Patients with Insomnia
Phase III Study of TS-142 in Patients with Insomnia
A Phase I Study of TS-172 in Healthy Adult Subjects (Single and Multiple Doses)
A Study to Evaluate Next Day Effects of TS-142 on Driving Performance in Healthy Subjects
Drug-drug Interaction Study with TS-142 in Healthy Adult Subjects (concomitant Administration of Itraconazole)
Late Phase II Study of TS-142 in Patients with Insomnia
Development and Validation of a Driving Simulator for Evaluating the Residual Effects of Drugs on Driving Performance - Sensitivity Analysis Using Zopiclone As a Positive Control
Safety, Pharmacokinetic, and Pharmacodynamic Study of TS-142 in Healthy Subjects
Clinical Study on Histamine H3 Receptor Occupancy of TS-091 by PET Examination in Healthy Adult Subjects
All 19 trials loaded